NCT01940510View on ClinicalTrials.gov

A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

RO5424802

Single dose without (Day 1) and with (Day 17) co-administration of rifampin

DRUG

rifampin

Multiple doses Days 8-16 and Days 17-20

Trial Locations (1)

78744

Austin

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01940510 - A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802 | Biotech Hunter | Biotech Hunter